BMRN
BioMarin Pharmaceutical Inc.
NASDAQ · Healthcare · Biotechnology · US
$66.35
−0.12%Forward multiples
Based on analyst estimates
- P/E forward
- 10.74x
- P/E 2026E
- 13.21x
- P/E 2027E
- 9.98x
- P/E 2028E
- 8.46x
- P/S forward
- 2.97x
Trailing multiples
Trailing twelve months
- P/E TTM
- 174.61x
- PEG TTM
- 0.11x
- Price / book
- 2.03x
- Price / sales
- 3.77x
- Price / cash flow
- 14.99x
Enterprise value
- Enterprise value
- $16.2B
- EV / sales
- 4.75x
- EV / EBITDA
- 41.93x
- EV / EBIT
- 59.18x
- Market cap
- $12.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026